PHI-1’s dual roles—supportive in normal physiology but dysregulated in cancer—likely arise from multifaceted functions of cellular PP1 holoenzymes, illustrating how its regulatory mechanisms can be subverted, contributing to malignancy. The gene discussed is PPP1R14B; the disease is cancer.